BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33216975)

  • 1. Improved stenosis outcome in stroke-free sickle cell anemia children after transplantation compared to chronic transfusion.
    Verlhac S; Gabor F; Paillard C; Chateil JF; Jubert C; Petras M; Grevent D; Brousse V; Petit P; Thuret I; Arnaud C; Kamdem A; Pondarré C; Gauthier A; de Montalembert M; Divialle-Doumdo L; Elmaleh M; Missud F; Guitton C; Bernaudin F;
    Br J Haematol; 2021 Apr; 193(1):188-193. PubMed ID: 33216975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design of the DREPAGREFFE trial: A prospective controlled multicenter study evaluating the benefit of genoidentical hematopoietic stem cell transplantation over chronic transfusion in sickle cell anemia children detected to be at risk of stroke by transcranial Doppler (NCT 01340404).
    Chevret S; Verlhac S; Ducros-Miralles E; Dalle JH; de Latour RP; de Montalembert M; Benkerrou M; Pondarré C; Thuret I; Guitton C; Lesprit E; Etienne-Julan M; Elana G; Vannier JP; Lutz P; Neven B; Galambrun C; Paillard C; Runel C; Jubert C; Arnaud C; Kamdem A; Brousse V; Missud F; Petras M; Doumdo-Divialle L; Berger C; Fréard F; Taieb O; Drain E; Elmaleh M; Vasile M; Khelif Y; Bernaudin M; Chadebech P; Pirenne F; Socié G; Bernaudin F
    Contemp Clin Trials; 2017 Nov; 62():91-104. PubMed ID: 28821470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Matched Sibling Donor Hematopoietic Stem Cell Transplantation With Transcranial Doppler Velocities in Children With Sickle Cell Anemia.
    Bernaudin F; Verlhac S; Peffault de Latour R; Dalle JH; Brousse V; Petras E; Thuret I; Paillard C; Neven B; Galambrun C; Divialle-Doumdo L; Pondarré C; Guitton C; Missud F; Runel C; Jubert C; Elana G; Ducros-Miralles E; Drain E; Taïeb O; Arnaud C; Kamdem A; Malric A; Elmaleh-Bergès M; Vasile M; Leveillé E; Socié G; Chevret S;
    JAMA; 2019 Jan; 321(3):266-276. PubMed ID: 30667500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic resonance imaging/angiography and transcranial Doppler velocities in sickle cell anemia: results from the SWiTCH trial.
    Helton KJ; Adams RJ; Kesler KL; Lockhart A; Aygun B; Driscoll C; Heeney MM; Jackson SM; Krishnamurti L; Miller ST; Sarnaik SA; Schultz WH; Ware RE;
    Blood; 2014 Aug; 124(6):891-8. PubMed ID: 24914136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sickle cell anemia: intracranial stenosis and silent cerebral infarcts in children with low risk of stroke.
    Arkuszewski M; Krejza J; Chen R; Ichord R; Kwiatkowski JL; Bilello M; Zimmerman R; Ohene-Frempong K; Melhem ER
    Adv Med Sci; 2014 Mar; 59(1):108-13. PubMed ID: 24797985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What is the place of hematopoietic stem cell transplantation in the management of cerebral vasculopathy in children with sickle cell anemia?
    Bernaudin F
    Hematol Oncol Stem Cell Ther; 2020 Sep; 13(3):121-130. PubMed ID: 32202243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.
    Adams RJ; McKie VC; Hsu L; Files B; Vichinsky E; Pegelow C; Abboud M; Gallagher D; Kutlar A; Nichols FT; Bonds DR; Brambilla D
    N Engl J Med; 1998 Jul; 339(1):5-11. PubMed ID: 9647873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normalized transcranial Doppler velocities, stroke prevention and improved pulmonary function after stem cell transplantation in children with sickle cell anemia.
    Mynarek M; Bettoni da Cunha Riehm C; Brinkmann F; Weißenborn K; Tell-Lüersen M; Heuft HG; Maecker-Kolhoff B; Sykora KW
    Klin Padiatr; 2013 May; 225(3):127-32. PubMed ID: 23625683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcranial Doppler velocity and brain MRI/MRA changes in children with sickle cell anemia on chronic transfusions to prevent primary stroke.
    Sheehan VA; Hansbury EN; Smeltzer MP; Fortner G; McCarville MB; Aygun B
    Pediatr Blood Cancer; 2013 Sep; 60(9):1499-502. PubMed ID: 23625812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic transfusion therapy on progression of neurovascular pathology in pediatric patients with sickle cell anemia.
    Bishop S; Matheus MG; Abboud MR; Cane ID; Adams RJ; Jackson SM; Kalpatthi R
    Blood Cells Mol Dis; 2011 Aug; 47(2):125-8. PubMed ID: 21724428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort.
    Bernaudin F; Verlhac S; Arnaud C; Kamdem A; Chevret S; Hau I; Coïc L; Leveillé E; Lemarchand E; Lesprit E; Abadie I; Medejel N; Madhi F; Lemerle S; Biscardi S; Bardakdjian J; Galactéros F; Torres M; Kuentz M; Ferry C; Socié G; Reinert P; Delacourt C
    Blood; 2011 Jan; 117(4):1130-40; quiz 1436. PubMed ID: 21068435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Magnetic resonance angiography in children with sickle cell disease and abnormal transcranial Doppler ultrasonography findings enrolled in the STOP study.
    Abboud MR; Cure J; Granger S; Gallagher D; Hsu L; Wang W; Woods G; Berman B; Brambilla D; Pegelow C; Lewin J; Zimmermann RA; Adams RJ;
    Blood; 2004 Apr; 103(7):2822-6. PubMed ID: 14684415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stroke prevention trial in sickle cell anemia.
    Adams RJ; McKie VC; Brambilla D; Carl E; Gallagher D; Nichols FT; Roach S; Abboud M; Berman B; Driscoll C; Files B; Hsu L; Hurlet A; Miller S; Olivieri N; Pegelow C; Scher C; Vichinsky E; Wang W; Woods G; Kutlar A; Wright E; Hagner S; Tighe F; Waclawiw MA
    Control Clin Trials; 1998 Feb; 19(1):110-29. PubMed ID: 9492971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease.
    Adams RJ; Brambilla D;
    N Engl J Med; 2005 Dec; 353(26):2769-78. PubMed ID: 16382063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How I manage cerebral vasculopathy in children with sickle cell disease.
    Brousse V; Kossorotoff M; de Montalembert M
    Br J Haematol; 2015 Sep; 170(5):615-25. PubMed ID: 25944412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons from the Stroke Prevention Trial in Sickle Cell Anemia (STOP) study.
    Adams RJ
    J Child Neurol; 2000 May; 15(5):344-9. PubMed ID: 10830201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of magnetic resonance angiography parameters on stroke prevention therapy in pediatric patients with sickle cell anemia.
    Strumph K; Morrone K; Dhillon P; Hsu K; Gomes W; Silver E; Lax D; Peng Q; Lee SK; Manwani D; Mitchell W
    Pediatr Blood Cancer; 2023 Feb; 70(2):e30109. PubMed ID: 36441603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease.
    Mirre E; Brousse V; Berteloot L; Lambot-Juhan K; Verlhac S; Boulat C; Dumont MD; Lenoir G; de Montalembert M
    Eur J Haematol; 2010 Mar; 84(3):259-65. PubMed ID: 19912310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red blood cell transfusion to treat or prevent complications in sickle cell disease: an overview of Cochrane reviews.
    Fortin PM; Hopewell S; Estcourt LJ
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012082. PubMed ID: 30067867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracranial vasculopathy and infarct recurrence in children with sickle cell anaemia, silent cerebral infarcts and normal transcranial Doppler velocities.
    Choudhury NA; DeBaun MR; Ponisio MR; Jordan LC; Rodeghier M; Pruthi S; McKinstry RC
    Br J Haematol; 2018 Oct; 183(2):324-326. PubMed ID: 29076125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.